Tempest Share Price

Tempest Share Price

NASDAQ: TPST | Micro Cap | Healthcare
$0.30
-$0.01 (-2.53%) Last updated on 20 Nov, 2026 | 01:56 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Tempest Stock Performance

Open
$0.31
Prev. Close
$0.30
Circuit Range
N/A
Day Range
$0.30 - $0.31
Year Range
$0.30 - $6.29
Volume
1,613
Average Traded
$0.30

Tempest Share Price Today

As of 20 November 2026, Tempest Therapeutics, Inc.'s share price is $0.30. The stock opened at $0.31, compared to its previous close of $0.30. During today's trading session, Tempest Therapeutics, Inc.'s share price traded between $0.30 and $0.31, with an average price of $0.30. Over the past 52 weeks, the stock has recorded a high of $6.29 and a low of $0.30. In terms of performance, Tempest Therapeutics, Inc.'s share price has declined by 80.71% over the last six months and is down 90.72% on a year-on-year basis.

Tempest Share Price Chart

Line chart of the Tempest price trend over the selected period. The price fell overall, ranging from 0.30 to 0.34, ending at 0.30.
$0.30$0.31
L
Show Current Price
H

Tempest Stock Fundamentals & Key Indicators

Market Cap
$1.23M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.99
Revenue (TTM)
$0.00
Return On Equity (TTM)
2173.99%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.85%

Tempest Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.02-$27.70-$5.24-$2.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-589.05%81.08%46.18%

Tempest Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$35.71-$29.49-$41.84-$26.26
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A17.42%-41.88%37.24%

Tempest Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets8.6610.0111.2413.14
Current Assets8.2731.4740.3632.95
Total Assets16.9341.4951.646.09
Non Current Liabilities6.958.1415.4220.7
Current Liabilities3.3114.229.417.28
Total Liabilities10.2622.3624.8427.98
Shareholders' Equity6.6719.1326.7718.11

Tempest Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-26.82-33.03-27.36-31.07
Investing0.0-0.44-0.17-0.56
Financing4.2624.535.611.4

Corporate Actions

Split
Ex-date: 30 Jan 2026

Split
Ex-date: 09 Apr 2025

About Tempest

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

Tempest Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.51
$0.30
-40.60%
Oct 2026
$0.80
$0.50
-39.61%
Sep 2026
$1.10
$0.83
-24.38%
Aug 2026
$0.88
$1.09
+26.59%
Jul 2026
$1.11
$0.86
-22.42%
Jun 2026
$1.52
$1.11
-27.60%
May 2026
$2.02
$1.54
-23.76%
Apr 2026
$1.65
$2.02
+24.69%
Mar 2026
$2.25
$1.62
-26.36%
Feb 2026
$2.47
$2.20
-19.56%
Jan 2026
$2.87
$2.73
-4.70%
Dec 2025
$3.20
$2.87
-10.31%

Tempest Share Price FAQs